Stock Scorecard
Stock Summary for National Health Investors Inc (NHI) - $62.32 as of 4/23/2024 6:45:29 AM EST
Total Score
10 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NHI
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NHI
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NHI
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for NHI
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for NHI
Financial Details for NHI
Company Overview |
|
---|---|
Ticker | NHI |
Company Name | National Health Investors Inc |
Country | USA |
Description | Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in the sale and leaseback, joint ventures, mortgages, and interim financing of discretionary and medical-based home and investment investments. in needs. |
Sector Name | REAL ESTATE & CONSTRUCTION |
Industry Name | REAL ESTATE INVESTMENT TRUSTS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/7/2024 |
Stock Price History |
|
Last Day Price | 62.32 |
Last Day Price Updated | 4/23/2024 6:45:29 AM EST |
Last Day Volume | 165,525 |
Average Daily Volume | 167,205 |
52-Week High | 62.93 |
52-Week Low | 44.52 |
Last Price to 52 Week Low | 39.98% |
Valuation Measures |
|
Trailing PE | 19.91 |
Industry PE | 57.83 |
Sector PE | 64.00 |
5-Year Average PE | 16.82 |
Free Cash Flow Ratio | 122.20 |
Industry Free Cash Flow Ratio | 158.86 |
Sector Free Cash Flow Ratio | 173.45 |
Current Ratio Most Recent Quarter | 0.28 |
Total Cash Per Share | 0.51 |
Book Value Per Share Most Recent Quarter | 33.73 |
Price to Book Ratio | 2.02 |
Industry Price to Book Ratio | 2.91 |
Sector Price to Book Ratio | 3.50 |
Price to Sales Ratio Twelve Trailing Months | 7.92 |
Industry Price to Sales Ratio Twelve Trailing Months | 6.36 |
Sector Price to Sales Ratio Twelve Trailing Months | 3.42 |
Share Statistics |
|
Total Shares Outstanding | 43,424,800 |
Market Capitalization | 2,706,233,536 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 3/27/2024 |
Last Dividend Amount | 0.90 |
Current Dividend Amount | 0.90 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 3.60 |
Trailing Annual Dividend Yield | 5.85% |
Forward Annual Dividend Rate | 3.46 |
Forward Annual Dividend Yield | 5.63% |
5-Year Dividend Payments Count | 20 |
3-Year Average Dividend Yield | 6.65% |
5-Year Average Dividend Yield | 6.30% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | -2.70% |
5-Year Dividend Growth Rate Percentage | -3.78% |
All-Time Dividend Growth Rate Percentage | 6.94% |
Dividend Payout Ratio | 115.02% |
Income Statement |
|
Quarterly Earnings Growth YOY | -14.10% |
Annual Earnings Growth | 104.29% |
Reported EPS 12 Trailing Months | 3.13 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 3.13 |
Net Income Twelve Trailing Months | 135,655,000 |
Net Income Past Year | 135,654,000 |
Net Income Prior Year | 66,403,000 |
Quarterly Revenue Growth YOY | -11.70% |
5-Year Revenue Growth | 1.66% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 22,347,000 |
Total Cash Past Year | 22,347,000 |
Total Cash Prior Year | 19,291,000 |
Net Cash Position Most Recent Quarter | -2,512,857,000 |
Net Cash Position Past Year | -2,512,857,000 |
Long Term Debt Past Year | 2,535,204,000 |
Long Term Debt Prior Year | 2,756,698,000 |
Total Debt Most Recent Quarter | 2,535,204,000 |
Equity to Debt Ratio Past Year | 0.33 |
Equity to Debt Ratio Most Recent Quarter | 0.33 |
Total Stockholder Equity Past Year | 1,253,952,000 |
Total Stockholder Equity Prior Year | 1,270,225,000 |
Total Stockholder Equity Most Recent Quarter | 1,253,952,000 |
Options |
|
Put/Call Ratio | 0.43 |
Has Options | False |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.41 |
MACD Signal | 0.48 |
20-Day Bollinger Lower Band | 50.00 |
20-Day Bollinger Middle Band | 56.74 |
20-Day Bollinger Upper Band | 63.48 |
Beta | 0.98 |
RSI | 61.26 |
50-Day SMA | 52.44 |
200-Day SMA | 51.81 |
System |
|
Modified | 4/23/2024 6:46:20 AM EST |